Why Rare Disease Research Has a Recruitment Problem

For people living with rare diseases and their families, the need for better treatments is urgent. Researchers are working to understand these conditions, identify potential therapies, and develop clinical trials that could change the future of care.

But before a study can begin answering important questions, researchers must find people who are eligible and willing to participate.

For rare diseases like frontotemporal degeneration (FTD), that can be particularly challenging. The relatively small number of people living with these conditions, combined with barriers to diagnosis, limited awareness of research opportunities, and the demands of participation, can make recruiting enough participants difficult.

Understanding these challenges is an important step toward addressing them.

A Small Participant Pool Makes Every Person Count

Rare diseases affect relatively small populations. For researchers, this means that the number of people who may qualify for a particular study is limited from the outset.

FTD presents an additional challenge because it is not a single disease. It encompasses a group of disorders that affect the frontal and temporal lobes of the brain, as well as related conditions.

Different studies may focus on specific diagnoses, symptoms, genetic variants, or stages of disease. As a result, a person who qualifies for one study may not be eligible for another.

For example, a clinical trial investigating a treatment for FTD associated with a particular genetic variant may require participants to have that specific genetic change. Other studies may focus on people with primary progressive aphasia (PPA), progressive supranuclear palsy (PSP), or another FTD-related disorder.

These eligibility requirements are important for conducting meaningful research, but they can further narrow an already small pool of potential participants.

When the number of eligible participants is limited, every person who chooses to take part in research has the potential to make a meaningful contribution.

Getting an Accurate Diagnosis Can Take Time

For many people impacted by FTD, the path to diagnosis is long and complicated.

Early symptoms may include changes in behavior, personality, language, or movement. Depending on the symptoms, FTD may initially be mistaken for a psychiatric condition, Alzheimer's disease, or another neurological disorder.

Some people experience symptoms for years before receiving an accurate diagnosis.

Delays in diagnosis can also mean delays in learning about research opportunities.

Certain studies have specific eligibility requirements related to diagnosis, disease progression, or the amount of time since symptoms began. By the time someone receives an accurate diagnosis, they may no longer qualify for a particular study.

Improving awareness of FTD among healthcare professionals and helping people access appropriate diagnostic resources can create more opportunities for individuals and families to consider research participation earlier in their journey.

People May Not Know That Research Opportunities Exist

Even when someone meets the eligibility requirements for a study, they may never hear about it.

Research opportunities are often shared through specialized medical centers, academic institutions, and clinical research networks. People who receive care outside these settings may have fewer opportunities to learn about studies that could be relevant to them.

Geography, access to specialized healthcare, and the availability of research information can all influence whether someone becomes aware of an opportunity.

There is also a common misconception that participating in research always means taking part in a clinical trial involving an experimental treatment.

In reality, research takes many forms.

Observational studies, surveys, natural history studies, genetic research, and clinical trials all contribute to advancing our understanding of rare diseases.

Some opportunities may involve sharing information about symptoms or experiences. Others may include medical assessments, biological samples, or testing an investigational treatment.

Helping people understand the different ways they can participate in research can make involvement feel more accessible.

It also gives individuals and families the information they need to decide which opportunities are appropriate for them.

Participating in Research Is Not Always Easy

Learning about a study is only the first step.

For people living with FTD and their care partners, participation may involve practical challenges that make enrolling in research difficult.

Some studies require travel to specialized research centers, multiple appointments, or extended periods away from home.

Transportation, caregiving responsibilities, employment, and the costs associated with travel can all affect a person's ability to participate.

FTD symptoms may create additional challenges. Changes in behavior, communication, mobility, or decision-making can make research visits more complicated, particularly as a condition progresses.

For some families, participating in a study may require a care partner to take time away from work, arrange additional support, or travel considerable distances.

These challenges can prevent people who are interested in research from taking part.

Expanding remote participation options, reducing unnecessary travel, and considering the needs of care partners can help make research more accessible.

For example, when a study allows participants to complete certain activities remotely, people who do not live near a major research center may have an opportunity to contribute.

Designing research around the realities of living with a rare disease can help reduce barriers while supporting meaningful participation.

Recruitment Takes Time, and Time Matters

Recruitment is a critical part of the research process.

Before researchers can evaluate a potential treatment or answer a scientific question, they must enroll enough eligible participants to produce meaningful results.

When enrollment is slower than anticipated, studies may take longer to complete. Delays can increase research costs, place additional demands on participating sites, and postpone the availability of findings that could inform future research.

In some cases, studies may struggle to meet their enrollment goals.

For rare diseases, these challenges can be particularly significant because relatively few potential participants may meet a study's specific requirements.

A community that is informed about research, understands the different ways to participate, and has opportunities to express interest can help researchers prepare for future studies.

Rather than beginning the process of identifying potential participants from scratch each time a new study launches, researchers can benefit from established research networks and registries that support awareness and engagement.

This is especially important as the FTD research landscape evolves and new studies seek participants with particular diagnoses, symptoms, or genetic characteristics.

Building a Research-Ready Community

Addressing the recruitment challenges facing rare disease research requires more than encouraging people to enroll in individual studies.

It requires building a research-ready community.

A research-ready community includes people who understand the role of research, know where to find information about opportunities, and have ways to contribute that reflect their circumstances and interests.

It also includes people who may not be eligible for a particular clinical trial today but could contribute to other types of research or become eligible for future studies.

For FTD, this means engaging not only people who have received a diagnosis but also care partners, biological family members, and others interested in advancing research.

It means recognizing that a person's relationship with FTD may change over time and that research participation can take different forms at different stages.

Registries can play an important role in this process.

By bringing together people impacted by rare diseases, registries can help build awareness of research, support participant engagement, and provide researchers with valuable information about the broader community.

For individuals and families, they can offer a way to stay informed about research without having to independently search for every new opportunity.

For researchers, registries can provide insights that help inform study planning, identify recruitment challenges, and support outreach to potential participants.

These efforts can help create a stronger foundation for research and reduce some of the barriers that have historically made recruitment difficult.

How the FTD Disorders Registry Supports Research

The FTD Disorders Registry was created to help advance research by bringing together people impacted by frontotemporal degeneration and providing opportunities for them to contribute to a growing body of knowledge about these disorders.

Anyone interested in FTD research can join the Registry to learn about research developments and opportunities to participate.

Eligible individuals in the United States and Canada can also enroll in the Registry Research Study, which collects information from people diagnosed with FTD, current and former care partners, and biological family members.

By sharing information about their experiences, participants can help researchers better understand FTD and the people impacted by it.

The Registry also supports the broader FTD research landscape by sharing information about research opportunities and helping researchers better understand the characteristics and experiences of potential study participants.

This information can help inform study design, recruitment planning, and future research priorities.

Through its outreach efforts, the Registry also supports research initiatives such as ALLFTD, helping to raise awareness of opportunities to participate and conducting remote follow-up with study participants.

Importantly, joining the Registry does not mean committing to participate in a clinical trial.

It offers people a way to become part of a research-ready community, stay informed, and consider opportunities that may be relevant to them.

Moving Rare Disease Research Forward

There is no single solution to the recruitment challenges facing rare disease research.

Earlier diagnosis, greater awareness of research opportunities, more accessible study designs, and sustained engagement with individuals and families all have important roles to play.

For FTD, progress depends on continued collaboration among researchers, healthcare professionals, advocacy organizations, and the people whose lives are affected by these disorders.

Every individual who chooses to contribute to research brings experiences and information that can help expand our understanding of FTD.

And while any one study may have specific eligibility requirements, there are many ways to contribute to the larger research effort.

By building a community that is informed, engaged, and ready to participate, we can help researchers overcome recruitment challenges and move promising research forward.

Because FTD is rare, every participant matters.

Be Part of the Next Chapter of FTD Research

Whether you have been diagnosed with FTD, are a current or former care partner, have a biological family connection to FTD, or simply want to support research, there is a place for you in the FTD Disorders Registry.

Join today to stay informed about FTD research, learn about opportunities to participate, and help build a research-ready community.

Join the FTD Disorders Registry